Literature DB >> 33394187

Long Non-coding RNA MEG3 Alleviated Ulcerative Colitis Through Upregulating miR-98-5p-Sponged IL-10.

Yan Wang1, Nan Wang1, Lianlian Cui1, Yan Li1, Zhenfeng Cao1, Xing Wu1, Qianhan Wang1, Bo Zhang1, Caixia Ma1, Yanbo Cheng2.   

Abstract

Ulcerative colitis (UC) is a refractory chronic colitis disease with the particularly complex cause. Recently, long noncoding RNAs (lncRNAs) have been reported to be related to the development of UC. LncRNA MEG3 has been proved to play an anti-inflammatory role in a variety of inflammatory diseases, which share similar pathogenesis with UC, indicating the potential involvement of lncRNA MEG3 in UC. This study aims to investigate the functional role and underlying mechanism of lncRNA MEG3 in UC. Gradient concentration of H2O2 (0, 20, 50, 100, and 200 μM) was used to induce Caco-2 damage models in vitro. Cell viability was detected by cell counting kit-8 (CCK-8) assay. LncRNA MEG3, miR-98-5p, and IL-10 levels in H2O2-treated Caco-2 cells were assessed by performing real-time quantitative polymerase chain reaction (RT-qPCR). Moreover, the binding relationship between lncRNA MEG3 and miR-98-5p, as well as the binding relationship between miR-98-5p and IL-10, was validated using dual-luciferase reporter assay. 2, 4, 6-Trinitrobenzenesulfonic acid solution (TNBS) was applied to induce ulcerative colitis in young rats. The body weight, disease activity index (DAI), length and weight of the colons, pathological scores of UC rats, reactive oxygen species (ROS), and inflammatory cytokines were determined to evaluate the effects of lncRNA MEG3 on the progression of UC. Besides, hematoxylin-eosin (HE) staining was exploited to observe histological changes of UC rat colons. In addition, western blotting analysis was also performed to evaluate the apoptosis and pyroptosis-related protein levels. Moreover, lncRNA MEG3, miR-98-5p, and IL-10 levels in UC rat colons were further assessed by RT-qPCR. Meanwhile, IL-10 expression was determined using immunohistochemistry. LncRNA MEG3 and IL-10 levels were distinctly decreased while miR-98-5p was increased in Caco-2 damage models and UC rats. Bioinformatics analysis predicted the binding sites of lncRNA MEG3 to miR-98-5p and miR-98-5p to IL-10. Besides, dual-luciferase reporter assay validated the negative correlation between lncRNA MEG3 and miR-98-5p, miR-98-5p, and IL-10. Overexpressed lncRNA MEG3 reduced. DAI scores and colon weight/length ratio improved UC ulceration. In addition, upregulation of lncRNA MEG3 relieved oxidative stress, inflammatory response, apoptosis, and pyroptosis of UC rat colons. LncRNA MEG3 overexpression alleviates the serve ulceration of UC rat colons by upregulating IL-10 expression via sponging miR-98-5p. To sum up, this study reveals the protective role of lncRNA MEG3 in the development of UC and may provide potential therapeutic targets for UC.

Entities:  

Keywords:  IL-10; LncRNA MEG3; Ulcerative colitis; miR-98-5p

Mesh:

Substances:

Year:  2021        PMID: 33394187     DOI: 10.1007/s10753-020-01400-z

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  2 in total

1.  Overexpression of long non-coding RNA TUG1 alleviates TNF-α-induced inflammatory injury in interstitial cells of Cajal.

Authors:  K Zhao; J-Y Tan; Q-D Mao; K-Y Ren; B-G He; C-P Zhang; L-Z Wei
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-01       Impact factor: 3.507

2.  MiR-98-5p expression inhibits polarization of macrophages to an M2 phenotype by targeting Trib1 in inflammatory bowel disease.

Authors:  Yunhua Peng; Qingyuan Wang; Wei Yang; Qiqi Yang; Ynani Pei; Wei Zhang
Journal:  Acta Biochim Pol       Date:  2020-04-03       Impact factor: 2.149

  2 in total
  7 in total

1.  Long Noncoding RNA FBXL19-AS1-Mediated Ulcerative Colitis-Associated Intestinal Epithelial Barrier Defect.

Authors:  Xun Zhao; De-Jun Cui; Liu-Chan Yang; Wen-Qiang Yuan; Fang Yan
Journal:  Tissue Eng Regen Med       Date:  2022-09-01       Impact factor: 4.451

Review 2.  Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models.

Authors:  Kanika Suri; Jason A Bubier; Michael V Wiles; Leonard D Shultz; Mansoor M Amiji; Vishnu Hosur
Journal:  Cells       Date:  2021-08-26       Impact factor: 7.666

3.  Mechanism of M2 macrophage-derived extracellular vesicles carrying lncRNA MEG3 in inflammatory responses in ulcerative colitis.

Authors:  Yu-Xuan Wang; Cheng Lin; Lu-Jia Cui; Tao-Zhi Deng; Qiu-Min Li; Feng-Ying Chen; Xin-Pu Miao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 4.  MicroRNAs as Potential Tools for Predicting Cancer Patients' Susceptibility to SARS-CoV-2 Infection and Vaccination Response.

Authors:  Tânia R Dias; Francisca Dias; Ana Luísa Teixeira; Hugo Sousa; Júlio Oliveira; Rui Medeiros
Journal:  Cells       Date:  2022-07-23       Impact factor: 7.666

5.  Construction, bioinformatics analysis, and validation of competitive endogenous RNA networks in ulcerative colitis.

Authors:  Longcong Dong; Ruibin Zhang; Qin Huang; Yuan Shen; Hongying Li; Shuguang Yu; Qiaofeng Wu
Journal:  Front Genet       Date:  2022-08-17       Impact factor: 4.772

6.  Identifying hub genes and miRNAs in Crohn's disease by bioinformatics analysis.

Authors:  Yuxin Sun; Daxing Cai; Weitao Hu; Taiyong Fang
Journal:  Front Genet       Date:  2022-08-31       Impact factor: 4.772

7.  LncRNA UCA1 Accelerates the Progression of Ulcerative Colitis via Mediating the miR-331-3p/BRD4 Axis.

Authors:  Jun Rao; Lihua Shao; Min Lin; Jin Huang; Li Fan
Journal:  Int J Gen Med       Date:  2021-06-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.